Metabolic biomarkers for chronic kidney disease

Archives of Biochemistry and Biophysics

Volumn 589, Issue , 2016, Pages 62-80

  Breit, Marc ^a   Weinberger, Klaus M ^a,b  

^a UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^b Forsyth House   (United Kingdom)

Author keywords

Biomarker discovery; Chronic kidney disease; Clinical validation; Metabolic biomarker; Multiparametric marker panels; Targeted metabolomics

Indexed keywords

ACYLCARNITINE; BIOLOGICAL MARKER; CREATININE; NITRIC OXIDE SYNTHASE; POLYAMINE;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; HUMAN; MACHINE LEARNING; METABOLISM; METABOLOMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH; TRYPTOPHAN METABOLISM; UREA CYCLE; ANIMAL; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; BIOMARKERS; HUMANS; METABOLOMICS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84951569421     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2015.07.018     Document Type: Article

References (209)

1. M.T. Ackermans, and E. Endert LC-MS/MS in endocrinology: what is the profit of the last 5 years? Bioanalysis 6 1 2014 Jan 43 57
2. H. Alani, A. Tamimi, and N. Tamimi Cardiovascular co-morbidity in chronic kidney disease: current knowledge and future research needs World J. Nephrol. 3 4 2014 156 168
3. E. Altmaier, S.L. Ramsay, A. Graber, H.W. Mewes, K.M. Weinberger, and K. Suhre Bioinformatics analysis of targeted metabolomics-uncovering old and new tales of diabetic mice under medication Endocrinology 149 7 2008 Jul 3478 3489
4. E. Altmaier, G. Kastenmüller, W. Römisch-Margl, B. Thorand, K.M. Weinberger, J. Adamski, T. Illig, A. Döring, and K. Suhre Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics Mol. Nutr. Food Res. 53 11 2009 Nov 1357 1365
5. E. Altmaier, G. Kastenmüller, W. Römisch-Margl, B. Thorand, K.M. Weinberger, T. Illig, J. Adamski, A. Döring, and K. Suhre Questionnaire-based self-reported nutrition habits associate with serum metabolism as revealed by quantitative targeted metabolomics Eur. J. Epidemiol. 26 2 2011 Feb 145 156
6. E. Alpaydin Introduction to Machine Learning second ed. 2009 The MIT Press Cambridge, MA
7. Á. Argilés, J. Siwy, F. Duranton, N. Gayrard, M. Dakna, U. Lundin, L. Osaba, C. Delles, G. Mourad, K.M. Weinberger, and H. Mischak CKD273, a new proteomics classifier assessing CKD and its prognosis PLoS One 8 5 2013 May 14 e62837
8. J.K. Aronson Monitoring therapy Br. J. Clin. Pharmacol. 60 3 2005 229 230
9. F.C. Barreto, D.V. Barreto, S. Liabeuf, N. Meert, G. Glorieux, M. Temmar, G. Choukroun, R. Vanholder, and Z.A. Massy European uremic toxin work group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients Clin. J. Am. Soc. Nephrol. 4 10 2009 Oct 1551 1558
10. G. Bartosz Peroxynitrite: mediator of the toxic action of nitric oxide Acta Biochim. Pol. 43 4 1996 645 659
11. C.A. Baumgartner A clinical metabolomics strategy to discover new biomarkers in complex disease: an overview Biomed. Tech. Berl. 2013 Sep 7 PubMed PMID: 24043029, pii:/j/bmte.2013.58.issue-s1-M/bmt-2013-4305/bmt-2013-4305.xml
12. C. Baumgartner, and A. Graber Data mining and knowledge discovery in metabolomics F. Masseglia, P. Poncelet, M. Teisseire, Successes and New Directions in Data Mining 2008 Information Science Reference London 141 166
13. C. Baumgartner, M. Osl, M. Netzer, and D. Baumgartner Bioinformatic-driven search for metabolic biomarkers in disease J. Clin. Bioinform. 1 1 2011 Jan 20 2
14. L. Baud, and R. Ardaillou Reactive oxygen species: production and role in the kidney Am. J. Physiol. 251 5 Pt 2 1986 Nov F765 F776
15. C. Baylis Nitric oxide deficiency in chronic kidney disease Am. J. Physiol. Ren. Physiol. 294 1 2008 Jan F1 F9
16. M. Berger, J.A. Gray, and B.L. Roth The expanded biology of serotonin Annu. Rev. Med. 60 2009 355 366
17. S.A. Berson, and R.S. Yalow General principles of radioimmunoassay Clin. Chim. Acta 22 1 1968 51 69
18. J. Bicker, A. Fortuna, G. Alves, and A. Falcão Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples-a review Anal. Chim. Acta 768 2013 Mar 20 12 34
19. S.M. Bode-Böger, F. Scalera, J.T. Kielstein, J. Martens-Lobenhoffer, G. Breithardt, M. Fobker, and H. Reinecke Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease J. Am. Soc. Nephrol. 17 4 2006 Apr 1128 1134
20. C.A. Böger, and I.M. Heid Chronic kidney disease: novel insights from genome-wide association studies Kidney Blood Press. Res. 34 4 2011 225 234
21. R.H. Böger, R. Maas, F. Schulze, and E. Schwedhelm Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality Clin. Chem. Lab. Med. 43 10 2005 1124 1129
22. C.A. Böger, and J.R. Sedor GWAS of diabetic nephropathy: is the GENIE out of the bottle? PLoS Genet. 8 9 2012 Sep e1002989
23. M. Breit, C. Baumgartner, and K.M. Weinberger Data handling and analysis in metabolomics Mohammadreza Khanmohammadi, Current Applications of Chemometrics 2015 Nova Science Publishers New York 181 203
24. B.E. Boser, I.M. Guyon, and V.N. Vapnik A training algorithm for optimal margin classifiers Proceedings of the Fifth Annual Workshop on Computational Learning Theory. ACM 1992 144 152
25. M. Breier, S. Wahl, C. Prehn, M. Fugmann, U. Ferrari, M. Weise, F. Banning, J. Seissler, H. Grallert, J. Adamski, and A. Lechner Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples PLoS One 9 2 2014 Feb 24 e89728
26. J. Bremer Carnitine-metabolism and functions Physiol. Rev. 63 4 1983 Oct 1420 1480
27. J. Bremer The role of carnitine in intracellular metabolism J. Clin. Chem. Clin. Biochem. 28 5 1990 May 297 301
28. Centers for Disease Control and Prevention (CDC) Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004 MMWR Morb. Mortal. Wkly. Rep. 56 8 2007 161 165
29. D.H. Chace, T.A. Kalas, and E.W. Naylor Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns Clin. Chem. 49 11 2003 Nov 1797 1817
30. J.C. Chambers, W. Zhang, G.M. Lord, P. van der Harst, D.A. Lawlor, J.S. Sehmi, and et al. Genetic loci influencing kidney function and chronic kidney disease Nat. Genet. 42 5 2010 May 373 375
31. M.R. Chao, Y.W. Hsu, H.H. Liu, J.H. Lin, and C.W. Hu Simultaneous detection of 3-nitrotyrosine and 3-nitro-4-hydroxyphenylacetic acid in human urine by online SPE LC-MS/MS and their association with oxidative and methylated dna lesions Chem. Res. Toxicol 28 5 2015 May 18 997 1006
32. J.Y. Choi, Y.J. Yoon, H.J. Choi, S.H. Park, C.D. Kim, I.S. Kim, T.H. Kwon, J.Y. Do, S.H. Kim, H. Ryu do, G.S. Hwang, and Y.L. Kim Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis Nephrol. Dial. Transpl. 26 4 2011 1304 1313
33. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
34. J. Coresh, E. Selvin, L.A. Stevens, J. Manzi, J.W. Kusek, P. Eggers, F. Van Lente, and A.S. Levey Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047
35. R. Counahan, C. Chantler, S. Ghazali, B. Kirkwood, F. Rose, and T.M. Barratt Estimation of glomerular filtration rate from plasma creatinine concentration in children Arch. Dis. Child. 51 11 1976 875 878
36. W.G. Couser, G. Remuzzi, S. Mendis, and M. Tonelli The contribution of chronic kidney disease to the global burden of major noncommunicable diseases Kidney Int. 80 12 2011 1258 1270
37. E. Critselis, and H. Lambers Heerspink Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression Nephrol. Dial. Transpl. 2015 Mar 19 pii: gfv062. [Epub ahead of print]
38. G.L. DeNardo, and S.J. DeNardo Concepts, consequences, and implications of theranosis Semin. Nucl. Med. 42 3 2012 147 150
39. T. Dimitroulas, A. Sandoo, and G.D. Kitas Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases Int. J. Mol. Sci. 13 10 2012 Sep 26 12315 12335
40. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices, Off J Eur Communities, 1998 Dec 7;L 331:1-37, [cited 2015 Apr 07] Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31998L0079.
41. P. Domingos A few useful things to know about machine learning Commun. ACM 55 10 2012 78 87
42. H. Duan, N. Guan, Y. Wu, J. Zhang, J. Ding, and B. Shao Identification of biomarkers for melamine-induced nephrolithiasis in young children based on ultra high performance liquid chromatography coupled to time-of-flight mass spectrometry (U-HPLC-Q-TOF/MS) J. Chromatogr. B 879 30 2011 3544 3550
43. W. Durante, F.K. Johnson, and R.A. Johnson Arginase: a critical regulator of nitric oxide synthesis and vascular function Clin. Exp. Pharmacol. Physiol. 34 9 2007 Sep 906 911
44. F. Duranton, U. Lundin, N. Gayrard, H. Mischak, M. Aparicio, G. Mourad, J.P. Daurès, K.M. Weinberger, and A. Argilés Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function Clin. J. Am. Soc. Nephrol. 9 1 2014 37 45
45. K.U. Eckardt, B. Bärthlein, S. Baid-Agrawal, A. Beck, M. Busch, F. Eitner, A.B. Ekici, J. Floege, O. Gefeller, H. Haller, R. Hilge, K.F. Hilgers, J.T. Kielstein, V. Krane, A. Köttgen, F. Kronenberg, P. Oefner, H.U. Prokosch, A. Reis, M. Schmid, E. Schaeffner, U.T. Schultheiss, S.A. Seuchter, T. Sitter, C. Sommerer, G. Walz, C. Wanner, G. Wolf, M. Zeier, and S. Titze The German chronic kidney disease (GCKD) study: design and methods Nephrol. Dial. Transpl. 27 4 2012 Apr 1454 1460
46. K.U. Eckardt, J. Coresh, O. Devuyst, R.J. Johnson, A. Köttgen, A.S. Levey, and A. Levin Evolving importance of kidney disease: from subspecialty to global health burden Lancet 382 9887 2013 158 169
47. Y. Egashira, S. Nagaki, and H. Sanada Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis Int. J. Vitam. Nutr. Res. 76 1 2006 Jan 28 33
48. M. El Nahas The global challenge of chronic kidney disease Kidney Int. 68 6 2005 2918 2929
49. D.P. Enot, B. Haas, and K.M. Weinberger Bioinformatics for mass spectrometry-based metabolomics Methods Mol. Biol. 719 2011 351 375
50. R.G. Fassett, S.K. Venuthurupalli, G.C. Gobe, J.S. Coombes, M.A. Cooper, and W.E. Hoy Biomarkers in chronic kidney disease: a review Kidney Int. 80 8 2011 Oct 806 821
51. S. Filip, C. Pontillo, J. Peter Schanstra, A. Vlahou, H. Mischak, and J. Klein Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases Expert Rev. Proteom. 11 5 2014 Oct 535 548
52. S. Fishbane, A.D. Hazzan, C. Halinski, and A.T. Mathew Challenges and opportunities in late-stage chronic kidney disease Clin. Kidney J. 8 1 2015 54 60
53. C. Fleck, A. Janz, F. Schweitzer, E. Karge, M. Schwertfeger, and G. Stein Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients Kidney Int. Suppl. 78 2001 Feb S14 S18
54. A. Floegel, N. Stefan, Z. Yu, K. Mühlenbruch, D. Drogan, H.G. Joost, A. Fritsche, H.U. Häring, M. Hrabe de Angelis, A. Peters, M. Roden, C. Prehn, R. Wang-Sattler, T. Illig, M.B. Schulze, J. Adamski, H. Boeing, and T. Pischon Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach Diabetes 62 2 2013 Feb 639 648
55. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J. Am. Soc. Nephrol. 9 12 Suppl 1998 S16 S23
56. C. Gieger, L. Geistlinger, E. Altmaier, M. Hrabé de Angelis, F. Kronenberg, T. Meitinger, H.W. Mewes, H.E. Wichmann, K.M. Weinberger, J. Adamski, T. Illig, and K. Suhre Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum PLoS Genet. 4 11 2008 Nov e1000282
57. O.N. Goek, A. Döring, C. Gieger, M. Heier, W. Koenig, C. Prehn, W. Römisch-Margl, R. Wang-Sattler, T. Illig, K. Suhre, P. Sekula, G. Zhai, J. Adamski, A. Köttgen, and C. Meisinger Serum metabolite concentrations and decreased GFR in the general population Am. J. Kidney Dis. 60 2 2012 Aug 197 206
58. O.N. Goek, C. Prehn, P. Sekula, W. Römisch-Margl, A. Döring, C. Gieger, M. Heier, W. Koenig, R. Wang-Sattler, T. Illig, K. Suhre, J. Adamski, A. Köttgen, and C. Meisinger Metabolites associate with kidney function decline and incident chronic kidney disease in the general population Nephrol. Dial. Transpl. 28 8 2013 Aug 2131 2138
59. A. Grassmann, S. Gioberge, S. Moeller, and G. Brown ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends Nephrol. Dial. Transpl. 20 12 2005 2587 2593
60. W.J. Griffiths, and J. Sjövall Bile acids: analysis in biological fluids and tissues J. Lipid Res. 51 1 2010 Jan 23 41
61. Y.M. Gu, L. Thijs, Y.P. Liu, Z. Zhang, L. Jacobs, T. Koeck, P. Zürbig, R. Lichtinghagen, K. Brand, T. Kuznetsova, L. Olivi, P. Verhamme, C. Delles, H. Mischak, and J.A. Staessen The urinary proteome as correlate and predictor of renal function in a population study Nephrol. Dial. Transpl. 29 12 2014 Dec 2260 2268
62. A. Gugliucci, and T. Menini The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease Adv. Exp. Med. Biol. 824 2014 191 208
63. H. Hagmann, and P.T. Brinkkoetter ROS and oxidative stress in CKD patients: is it the mitochondria that keeps CKD patients in bed? Nephrol. Dial. Transplant 30 6 2015 Jun 867 868
64. R. Hardeland, S.R. Pandi-Perumal, and D.P. Cardinali Melatonin Int. J. Biochem. Cell Biol. 38 3 2006 Mar 313 316
65. J.L. Harden, and N.K. Egilmez Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity Immunol. Invest. 41 6-7 2012 738 764
66. J.R. Harris, P. Burton, B.M. Knoppers, K. Lindpaintner, M. Bledsoe, A.J. Brookes, I. Budin-Ljøsne, R. Chisholm, D. Cox, M. Deschênes, I. Fortier, P. Hainaut, R. Hewitt, J. Kaye, J.E. Litton, A. Metspalu, B. Ollier, L.J. Palmer, A. Palotie, M. Pasterk, M. Perola, P.H. Riegman, G.J. van Ommen, M. Yuille, and K. Zatloukal Toward a roadmap in global biobanking for health Eur. J. Hum. Genet. 20 11 2012 Nov 1105 1111
67. H.A. Hauer, I.M. Bajema, H.C. Van Houwelingen, F. Ferrario, L.H. Noël, R. Waldherr, D.R. Jayne, N. Rasmussen, J.A. Bruijn, and E.C. Hagen European Vasculitis Study Group (EUVAS). Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients Kidney Int. 62 5 2002 1732 1742
68. K. Hayashi, H. Sasamura, T. Hishiki, M. Suematsu, S. Ikeda, T. Soga, and H. Itoh Use of serum and urine metabolome analysis for the detection of metabolic changes in patients with stage 1-2 chronic kidney disease Nephro Urology Mon. 3 03 2011 164 171
69. G.L. Hedlund, N. Longo, and M. Pasquali Glutaric acidemia type 1 Am. J. Med. Genet. C Semin. Med. Genet. 142C 2 2006 May 15 86 94
70. A. Hirayama, E. Nakashima, M. Sugimoto, S. Akiyama, W. Sato, S. Maruyama, S. Matsuo, M. Tomita, Y. Yuzawa, and T. Soga Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy Anal. Bioanal. Chem. 404 10 2012 Dec 3101 3109
71. F.F. Hou, D. Xie, X. Zhang, P.Y. Chen, W.R. Zhang, M. Liang, Z.J. Guo, and J.P. Jiang Renoprotection of optimal antiproteinuric doses (ROAD) study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency J. Am. Soc. Nephrol. 18 6 2007 Jun 1889 1898
72. X. Huang, P. Sjögren, J. Ärnlöv, T. Cederholm, L. Lind, P. Stenvinkel, B. Lindholm, U. Risérus, and J.J. Carrero Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease J. Intern Med. 275 1 2014 Jan 71 83
73. T. Illig, C. Gieger, G. Zhai, W. Römisch-Margl, R. Wang-Sattler, C. Prehn, E. Altmaier, G. Kastenmüller, B.S. Kato, H.W. Mewes, T. Meitinger, M.H. de Angelis, F. Kronenberg, N. Soranzo, H.E. Wichmann, T.D. Spector, J. Adamski, and K. Suhre A genome-wide perspective of genetic variation in human metabolism Nat. Genet. 42 2 2010 Feb 137 141
74. J.A. Imlay, and S. Linn DNA damage and oxygen radical toxicity Science 240 4857 1988 Jun 3 1302 1309
75. N. Issa, K.H. Meyer, S. Arrigain, G. Choure, R.A. Fatica, S. Nurko, B.R. Stephany, and E.D. Poggio Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors Transplantation 86 2 2008 Jul 27 223 230
76. W. Jäger, A. Gruber, B. Giessrigl, G. Krupitza, T. Szekeres, and D. Sonntag Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231 OMICS 15 1-2 2011 Jan-Feb 9 14
77. L. Jia, J. Chen, P. Yin, X. Lu, and G. Xu Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry Metabolomics 4 2 2008 183 189
78. M. Jaremek, Z. Yu, M. Mangino, K. Mittelstrass, C. Prehn, P. Singmann, T. Xu, N. Dahmen, K.M. Weinberger, K. Suhre, A. Peters, A. Döring, H. Hauner, J. Adamski, T. Illig, T.D. Spector, and R. Wang-Sattler Alcohol-induced metabolomic differences in humans Transl. Psychiatry 3 2013 Jul 2 e276
79. T.S. Johnson, and D.H. Munn Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance Immunol. Invest. 41 6-7 2012 765 797
80. W. Ju, F. Eichinger, M. Bitzer, J. Oh, S. McWeeney, C.C. Berthier, K. Shedden, C.D. Cohen, A. Henger, S. Krick, J.B. Kopp, C.J. Stoeckert Jr., S. Dikman, B. Schröppel, D.B. Thomas, D. Schlondorff, M. Kretzler, and E.P. Böttinger Renal gene and protein expression signatures for prediction of kidney disease progression Am. J. Pathol. 174 6 2009 Jun 2073 2085
81. E.J. Kaleta, A.E. Clark, A. Cherkaoui, V.H. Wysocki, E.L. Ingram, J. Schrenzel, and D.M. Wolk Comparative analysis of PCR-electrospray ionization/mass spectrometry (MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles Clin. Chem. 57 7 2011 Jul 1057 1067
82. J.T. Kielstein, S.R. Salpeter, S.M. Bode-Boeger, J.P. Cooke, and D. Fliser Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis Nephrol. Dial. Transpl. 21 9 2006 Sep 2446 2451
83. T. Koal, D. Schmiederer, H. Pham-Tuan, C. Röhring, and M. Rauh Standardized LC-MS/MS based steroid hormone profile-analysis J. Steroid Biochem. Mol. Biol. 129 3-5 2012 Apr 129 138
84. G.J. Ko, D.N. Grigoryev, D. Linfert, H.R. Jang, T. Watkins, C. Cheadle, L. Racusen, and H. Rabb Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition Am. J. Physiol. Ren. Physiol. 298 6 2010 Jun F1472 F1483
85. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 5517 1975 495 497
86. S. Kölker, E. Christensen, J.V. Leonard, C.R. Greenberg, A. Boneh, A.B. Burlina, A.P. Burlina, M. Dixon, M. Duran, A. García Cazorla, S.I. Goodman, D.M. Koeller, M. Kyllerman, C. Mühlhausen, E. Müller, J.G. Okun, B. Wilcken, G.F. Hoffmann, and P. Burgard Diagnosis and management of glutaric aciduria type I-revised recommendations J. Inherit. Metab. Dis. 34 3 2011 Jun 677 694
87. A. Köttgen Genome-wide association studies in nephrology research Am. J. Kidney Dis. 56 4 2010 Oct 743 758
88. A. Konvalinka Urine proteomics for acute kidney injury prognosis: another player and the long road ahead Kidney Int. 85 4 2014 Apr 735 738
89. J.D. Kopple Phenylalanine and tyrosine metabolism in chronic kidney failure J. Nutr. 137 6 Suppl. 1 2007 Jun 1586S 1590S discussion 1597S-1598S
90. Y. Kotake, and I. Masayama The intermediary metabolism of tryptophan. XVIII. The mechanism of formation of kynurenine from tryptophan Z Physiol. Chem. 243 1936 237 244
91. C.D. Krause, Z.H. Yang, Y.S. Kim, J.H. Lee, J.R. Cook, and S. Pestka Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential Pharmacol. Ther. 113 1 2007 Jan 50 87
92. A.K. Krug, S. Gutbier, L. Zhao, D. Pöltl, C. Kullmann, V. Ivanova, S. Förster, S. Jagtap, J. Meiser, G. Leparc, S. Schildknecht, M. Adam, K. Hiller, H. Farhan, T. Brunner, T. Hartung, A. Sachinidis, and M. Leist Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+) Cell Death Dis. 5 2014 May 8 e1222
93. Y.W. Lee Simultaneous screening of 177 drugs of abuse in urine using ultra-performance liquid chromatography with tandem mass spectrometry in drug-intoxicated patients Clin. Psychopharmacol. Neurosci. 11 3 2013 Dec 158 164
94. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann. Intern Med. 130 6 1999 461 470
95. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, and F. Van Lente Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann. Intern Med. 145 4 2006 247 254
96. A.S. Levey, R. Atkins, J. Coresh, E.P. Cohen, A.J. Collins, K.U. Eckardt, M.E. Nahas, B.L. Jaber, M. Jadoul, A. Levin, N.R. Powe, J. Rossert, D.C. Wheeler, N. Lameire, and G. Eknoyan Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes Kidney Int. 72 3 2007 247 259
97. A.S. Levey, L.A. Inker, and J. Coresh GFR estimation: from physiology to public health Am. J. Kidney Dis. 63 5 2014 May 820 834
98. Y. Li, and A. Köttgen Genetic investigations of kidney disease: core curriculum 2013 Am. J. Kidney Dis. 61 5 2013 May 832 844
99. S. Lopez-Giacoman, and M. Madero Biomarkers in chronic kidney disease, from kidney function to kidney damage World J. Nephrol. 4 1 2015 Feb 6 57 73
100. U. Lundin Biomarker Discovery in Diabetic Nephropathy by Targeted Metabolomics Master's thesis 2008 Linköping University Linköping, Sweden
101. Lundin U, Weinberger K (Inventors), Biocrates Life Sciences AG (Assignee), New biomarkers for assessing kidney diseases, International patent WO/2010/139341, Published 2010 Dec 09.
102. U. Lundin, R. Modre-Osprian, and K.M. Weinberger Targeted metabolomics for clinical biomarker discovery in multifactorial diseases K. Ikehara, Advances in the Study of Genetic Disorders 2011 InTech Croatia 81 98
103. C. Ma, K. Bi, D. Su, W. Ji, M. Zhang, X. Fan, C. Wang, and X. Chen Serum and kidney metabolic changes of rat nephrotoxicity induced by Morning Glory Seed Food Chem. Toxicol. 48 10 2010 Oct 2988 2993
104. A.J. Matas, J.M. Smith, M.A. Skeans, K.E. Lamb, S.K. Gustafson, C.J. Samana, D.E. Stewart, J.J. Snyder, A.K. Israni, and B.L. Kasiske OPTN/SRTR 2011 annual data report: kidney Am. J. Transpl. 13 Suppl. 1 2013 Jan 11 46
105. J. McCarthy, M.L. Minsky, N. Rochester, and C.E. Shannon A proposal for the dartmouth summer research project on artificial intelligence [cited 2015 Apr 07] Available from: http://jmc.stanford.edu/articles/dartmouth/dartmouth.pdf 1955 Aug 31
106. J. McCarthy, M.L. Minsky, N. Rochester, and C.E. Shannon A proposal for the dartmouth summer research project on artificial intelligence, august 31, 1955 AI Mag. 27 4 2006 12
107. G.M. McMahon, and S.S. Waikar Biomarkers in nephrology: core curriculum 2013 Am. J. Kidney Dis. 62 1 2013 Jul 165 178
108. R.H. McMenamy, and J.L. Oncley The specific binding of L-tryptophan to serum albumin J. Biol. Chem. 233 6 1958 Dec 1436 1447
109. A. Mehrabi, H. Fonouni, M. Golriz, B. Schmied, M. Tahmasbirad, J. Weitz, M.W. Büchler, M. Zeier, and J. Schmidt Living-donor kidney transplantation Chirurg 81 9 2010 Sep 794, 796-800, 802-3. [Article in German]
110. E. Mishima, C. Inoue, D. Saigusa, R. Inoue, K. Ito, Y. Suzuki, and et al. Conformational change in transfer RNA is an early indicator of acute cellular damage J. Am. Soc. Nephrol. 25 10 2014 Oct 2316 2326
111. M.E. Mitchell Carnitine metabolism in human subjects. I. Normal metabolism Am. J. Clin. Nutr. 31 2 1978 Feb 293 306
112. K. Mullis, F. Faloona, S. Scharf, R. Saiki, G. Horn, and H. Erlich Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction Cold Spring Harb. Symp. Quant. Biol. 51 Pt 1 1986 263 273
113. D.H. Munn, and A.L. Mellor Indoleamine 2,3 dioxygenase and metabolic control of immune responses Trends Immunol. 34 3 2013 Mar 137 143
114. K. Murata, N.A. Baumann, A.K. Saenger, T.S. Larson, A.D. Rule, and J.C. Lieske Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations Clin. J. Am. Soc. Nephrol. 6 8 2011 Aug 1963 1972
115. G.J. Navis, P.J. Blankestijn, J. Deegens, J.W. De Fijter, J.J. Homan van der Heide, T. Rabelink, R.T. Krediet, A.J. Kwakernaak, G.D. Laverman, K.M. Leunissen, P. van Paassen, M.G. Vervloet, P.M. Wee, J.F. Wetzels, R. Zietse, and F.J. van Ittersum BIND-NL investigators. The biobank of nephrological diseases in the Netherlands cohort: the string of pearls initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands Nephrol. Dial. Transpl. 29 6 2014 Jun 1145 1150
116. M. Netzer, K.G. Kugler, L.A. Müller, K.M. Weinberger, A. Graber, C. Baumgartner, and M. Dehmer A network-based feature selection approach to identify metabolic signatures in disease J. Theor. Biol. 310 2012 Oct 7 216 222
117. T. Niwa Indoxyl sulfate is a nephro-vascular toxin J. Ren. Nutr. 20 5 Suppl 2010 Sep S2 S6
118. E. Nkuipou-Kenfack, F. Duranton, N. Gayrard, À. Argilés, U. Lundin, K.M. Weinberger, M. Dakna, C. Delles, W. Mullen, H. Husi, J. Klein, T. Koeck, P. Zürbig, and H. Mischak Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease PLoS One 9 5 2014 e96955
119. K.H. Oh, S.K. Park, H.C. Park, H.J. Chin, D.W. Chae, K.H. Choi, S.H. Han, T.H. Yoo, K. Lee, Y.S. Kim, W. Chung, Y.H. Hwang, S.W. Kim, Y.H. Kim, S.W. Kang, B.J. Park, and J. Lee Ahn C1; Representing KNOW-CKD study group. KNOW-CKD (KoreaN cohort study for outcome in patients with chronic kidney disease): design and methods BMC Nephrol. 15 2014 May 19 80
120. Y. Okada, X. Sim, M.J. Go, J.Y. Wu, D. Gu, F. Takeuchi, A. Takahashi, S. Maeda, T. Tsunoda, P. Chen, S.C. Lim, T.Y. Wong, J. Liu, T.L. Young, T. Aung, M. Seielstad, Y.Y. Teo, Y.J. Kim, J.Y. Lee, B.G. Han, D. Kang, C.H. Chen, F.J. Tsai, L.C. Chang, S.J. Fann, H. Mei, D.C. Rao, J.E. Hixson, S. Chen, T. Katsuya, M. Isono, T. Ogihara, J.C. Chambers, W. Zhang, J.S. Kooner KidneyGen Consortium; CKDGen Consortium E. Albrecht GUGC consortium K. Yamamoto, M. Kubo, Y. Nakamura, N. Kamatani, N. Kato, J. He, Y.T. Chen, Y.S. Cho, E.S. Tai, and T. Tanaka Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations Nat. Genet. 44 8 2012 Jul 15 904 909
121. M. Ozaki Metabolism of monoamines in spontaneously hypertensive rat Jpn. J. Pharmacol. 16 3 1966 257 263
122. P.S. Parfrey, and R.N. Foley The clinical epidemiology of cardiac disease in chronic renal failure J. Am. Soc. Nephrol. 10 7 1999 1606 1615
123. C.W. Park Diabetic kidney disease: from epidemiology to clinical perspectives Diabetes Metab. J. 38 4 2014 252 260
124. M.J. Pena, H.J. Lambers Heerspink, M.E. Hellemons, T. Friedrich, G. Dallmann, M. Lajer, S.J. Bakker, R.T. Gansevoort, P. Rossing, D. de Zeeuw, and S.S. Roscioni Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with type 2 diabetes mellitus Diabet. Med. 31 9 2014 Sep 1138 1147
125. J. Pichler Hefti, D. Sonntag, U. Hefti, L. Risch, O.D. Schoch, A.J. Turk, T. Hess, K.E. Bloch, M. Maggiorini, T.M. Merz, K.M. Weinberger, and A.R. Huber Oxidative stress in hypobaric hypoxia and influence on vessel-tone modifying mediators High. Alt. Med. Biol. 14 3 2013 Sep 273 279
126. N.A. Porter, S.E. Caldwell, and K.A. Mills Mechanisms of free radical oxidation of unsaturated lipids Lipids 30 4 1995 Apr 277 290
127. P.M. Price, K. Hirschhorn, and R.L. Safirstein Chronic kidney disease and GWAS: "the proper study of mankind is man" Cell Metab. 11 6 2010 Jun 9 451 452
128. N.G. Psihogios, R.G. Kalaitzidis, S. Dimou, K.I. Seferiadis, K.C. Siamopoulos, and E.T. Bairaktari Evaluation of tubulointerstitial lesions' severity in patients with glomerulonephritides: an NMR-based metabonomic study J. Proteome Res. 6 9 2007 3760 3770
129. 1H NMR-spectroscopy Clin. Transl. Sci. 5 5 2012 379 385
130. N.D. Quach, R.D. Arnold, and B.S. Cummings Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease Biochem. Pharmacol. 90 4 2014 Aug 15 338 348
131. A. Ramezani, and D.S. Raj The gut microbiome, kidney disease, and targeted interventions J. Am. Soc. Nephrol. 25 4 2014 Apr 657 670
132. Ramsay SL, Stoeggl WM, Weinberger KM, Graber A, Guggenbichler W (Inventors). Biocrates Life Sciences AG (Assignee), Apparatus and method for analyzing a metabolite profile, International patent WO/2007/003343, Published 2007 Jan 11.
133. Ramsay SL, Guggenbichler W, Weinberger KM, Graber A, Stoeggl WM (Inventors). Biocrates Life Sciences AG (Assignee), Device for quantitative analysis of a drug or metabolite profile, International patent WO/2007/003344, Published 2007 Jan 11.
134. E.P. Rhee, A. Souza, L. Farrell, M.R. Pollak, G.D. Lewis, D.J. Steele, R. Thadhani, C.B. Clish, A. Greka, and R.E. Gerszten Metabolite profiling identifies markers of uremia J. Am. Soc. Nephrol. 21 6 2010 1041 1051
135. S. Robinson, R. Pool, and R. Giffin Emerging Safety Science: Workshop Summary. Forum on Drug Discovery, Development, and Translation 2008 The National Academies Press Washington D.C [cited 2015 Apr 06]. Available from: http://www.nap.edu/catalog/11975/emerging-safety-science-workshop-summary
136. W. Röschinger, B. Olgemöller, R. Fingerhut, B. Liebl, and A.A. Roscher Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases Eur. J. Pediatr. 162 Suppl. 1 2003 Dec S67 S76
137. E.M. Rogers Diffusion of Innovations 1962 Free Press of Glencoe New York
138. P. Ruggenenti, A. Schieppati, and G. Remuzzi Progression, remission, regression of chronic renal diseases Lancet 357 9268 2001 May 19 1601 1608
139. P. Ruggenenti, E. Perticucci, P. Cravedi, V. Gambara, M. Costantini, S.K. Sharma, A. Perna, and G. Remuzzi Role of remission clinics in the longitudinal treatment of CKD J. Am. Soc. Nephrol. 19 6 2008 Jun 1213 1224
140. A. Saito, T. Takagi, T.G. Chung, and K. Ohta Serum levels of polyamines in patients with chronic renal failure Kidney Int. Suppl. 16 1983 Dec S234 S237
141. K. Saito, S. Fujigaki, M.P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Noma, and M. Seishima Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency Am. J. Physiol. Ren. Physiol. 279 3 2000 Sep F565 F572
142. A.L. Samuel Some studies in machine learning using the game of checkers IBM J. Res. Dev. 3 3 1959 210 229
143. F. Sanger, and A.R. Coulson A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase J. Mol. Biol. 94 3 1975 441 448
144. E. Sasaki, Y. Ohta, R. Shinohara, and I. Ishiguro Contribution of serum albumin to the transport of orally administered L-tryptophan into liver of rats with L-tryptophan depletion Amino Acids 16 1 1999 29 39
145. E. Sato, M. Kohno, M. Yamamoto, T. Fujisawa, K. Fujiwara, and N. Tanaka Metabolomic analysis of human plasma from haemodialysis patients Eur. J. Clin. Invest. 41 3 2011 241 255
146. J.P. Schanstra, and H. Mischak Proteomic urinary biomarker approach in renal disease: from discovery to implementation Pediatr. Nephrol. 30 5 2015 May 713 725
147. M. Sebag A tour of machine learning: an AI perspective AI Commun. 27 1 2014 11 23
148. C. Seger, K. Tentschert, W. Stöggl, A. Griesmacher, and S.L. Ramsay A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples Nat. Protoc. 4 4 2009 526 534
149. V.O. Shah, R.R. Townsend, H.I. Feldman, K.L. Pappan, E. Kensicki, and D.L. Vander Jagt Plasma metabolomic profiles in different stages of CKD Clin. J. Am. Soc. Nephrol. 8 3 2013 Mar 363 370
150. K. Sharma Obesity, oxidative stress, and fibrosis in chronic kidney disease Kidney Int. Suppl. (2011) 4 1 2014 Nov 113 117
151. J. Siwy, J.P. Schanstra, A. Argiles, S.J. Bakker, J. Beige, P. Boucek, K. Brand, C. Delles, F. Duranton, B. Fernandez-Fernandez, M.L. Jankowski, M. Al Khatib, T. Kunt, M. Lajer, R. Lichtinghagen, M. Lindhardt, D.M. Maahs, H. Mischak, W. Mullen, G. Navis, M. Noutsou, A. Ortiz, F. Persson, J.R. Petrie, J.M. Roob, P. Rossing, P. Ruggenenti, I. Rychlik, A.L. Serra, J. Snell-Bergeon, G. Spasovski, O. Stojceva-Taneva, M. Trillini, H. von der Leyen, B.M. Winklhofer-Roob, P. Zürbig, and J. Jankowski Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy Nephrol. Dial. Transpl. 29 8 2014 Aug 1563 1570
152. R.J. Solomonoff An inductive inference machine. IRE convention record Sect. Inf. Theory 2 1957 56 62
153. R.J. Solomonoff A formal theory of inductive inference. Part I Inf. Control 7 1 1964 1 22
154. Sonntag D, Koal T, Ramsay SL, Dammeier S, Weinberger KM, Unterwurzacher I (Inventors), Biocrates Life Sciences AG (Assignee). Inflammation and oxidative stress level assay, International patent WO/2008/145384. Published 2008 Dec 4.
155. J.M. Souza, G. Peluffo, and R. Radi Protein tyrosine nitration-functional alteration or just a biomarker? Free Radic. Biol. Med. 45 4 2008 Aug 15 357 366
156. E.M. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis J. Mol. Biol. 98 3 1975 503 517
157. B. Stengel, C. Combe, C. Jacquelinet, S. Briançon, D. Fouque, M. Laville, L. Frimat, C. Pascal, Y.E. Herpe, J.F. Deleuze, J. Schanstra, R.L. Pisoni, B.M. Robinson, and Z.A. Massy The French chronic kidney disease-renal epidemiology and information network (CKD-REIN) cohort study Nephrol. Dial. Transpl. 29 8 2014 Aug 1500 1507
158. K. Suhre, C. Meisinger, A. Döring, E. Altmaier, P. Belcredi, C. Gieger, D. Chang, M.V. Milburn, W.E. Gall, K.M. Weinberger, H.W. Mewes, M. Hrabé de Angelis, H.E. Wichmann, F. Kronenberg, J. Adamski, and T. Illig Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting PLoS One 5 11 2010 Nov 11 e13953
159. K. Suhre, S.Y. Shin, A.K. Petersen, R.P. Mohney, D. Meredith, B. Wägele, E. Altmaier, CARDIoGRAM, P. Deloukas, J. Erdmann, E. Grundberg, C.J. Hammond, M.H. de Angelis, G. Kastenmüller, A. Köttgen, F. Kronenberg, M. Mangino, C. Meisinger, T. Meitinger, H.W. Mewes, M.V. Milburn, C. Prehn, J. Raffler, J.S. Ried, W. Römisch-Margl, N.J. Samani, K.S. Small, H.E. Wichmann, G. Zhai, T. Illig, T.D. Spector, J. Adamski, N. Soranzo, and C. Gieger Human metabolic individuality in biomedical and pharmaceutical research Nature 477 7362 2011 Aug 31 54 60
160. W. Sui, L. Li, W. Che, Z. Guimai, J. Chen, W. Li, and Y. Dai A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy Clin. (Sao Paulo) 67 4 2012 363 373
161. C.C. Sung, Y.C. Hsu, C.C. Chen, Y.F. Lin, and C.C. Wu Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease Oxid. Med. Cell Longev. 2013 2013 301982
162. M.E. Swendseid, M. Panaqua, and J.D. Kopple Polyamine concentrations in red cells and urine of patients with chronic renal failure Life Sci. 26 7 1980 Feb 18 533 539
163. C.C. Szeto, K.B. Ching-Ha, L. Ka-Bik, L.F. Mac-Moune, C.P. Cheung-Lung, W. Gang, C. Kai-Ming, and L.P. Kam-Tao Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases Dis. Markers 33 3 2012 137 144
164. O. Takikawa Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism Biochem. Biophys. Res. Commun. 338 1 2005 Dec 9 12 19
165. H. Tent, M. Rook, L.A. Stevens, W.J. van Son, L.J. van Pelt, H.S. Hofker, R.J. Ploeg, J.J. van der Heide, and G. Navis Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function Clin. J. Am. Soc. Nephrol. 5 11 2010 1960 1968
166. P.I. Terasaki, J.M. Cecka, D.W. Gjertson, and S. Takemoto High survival rates of kidney transplants from spousal and living unrelated donors N. Engl. J. Med. 333 6 1995 Aug 10 333 336
167. M. Thevis, A. Thomas, and W. Schänzer Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods Anal. Bioanal. Chem. 405 30 2013 Dec 9655 9667
168. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. U. S. A. 76 9 1979 4350 4354
169. D. Tsikas, A. Mitschke, and F.M. Gutzki Measurement of 3-nitro-tyrosine in human plasma and urine by gas chromatography-tandem mass spectrometry Methods Mol. Biol. 828 2012 255 270
170. A.M. Turing Computing machinery and intelligence Mind 49 1950 433 460
171. United States Renal Data System (USRDS) Annual Data Report [homepage on the Internet] 2013 No date [cited 2015 Mar 25]. Available from: http://www.usrds.org/2013/pdf/v2-ch1-13.pdf
172. I. Unterwurzacher, T. Koal, G.K. Bonn, K.M. Weinberger, and S.L. Ramsay Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes Clin. Chem. Lab. Med. 46 11 2008 1589 1597
173. P. Vallance, A. Leone, A. Calver, J. Collier, and S. Moncada Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 8793 1992 Mar 7 572 575
174. J.M. van den Ouweland, M. Vogeser, and S. Bächer Vitamin D and metabolites measurement by tandem mass spectrometry Rev. Endocr. Metab. Disord. 14 2 2013 Jun 159 184
175. G.J. van Ommen, O. Törnwall, C. Bréchot, G. Dagher, J. Galli, K. Hveem, U. Landegren, C. Luchinat, A. Metspalu, C. Nilsson, O.V. Solesvik, M. Perola, J.E. Litton, and K. Zatloukal BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres Eur. J. Hum. Genet 23 7 2015 Jul 893 900
176. S. Vegter, A. Perna, M.J. Postma, G. Navis, G. Remuzzi, and P. Ruggenenti Sodium intake, ACE inhibition, and progression to ESRD J. Am. Soc. Nephrol. 23 1 2012 165 173
177. M. Vogeser, and C. Seger A decade of HPLC-MS/MS in the routine clinical laboratory-goals for further developments Clin. Biochem. 41 9 2008 Jun 649 662
178. W. Vogt Oxidation of methionyl residues in proteins: tools, targets, and reversal Free Radic. Biol. Med. 18 1 1995 Jan 93 105
179. T.J. Wang, M.G. Larson, R.S. Vasan, S. Cheng, E.P. Rhee, E. McCabe, G.D. Lewis, C.S. Fox, P.F. Jacques, C. Fernandez, C.J. O'Donnell, S.A. Carr, V.K. Mootha, J.C. Florez, A. Souza, O. Melander, C.B. Clish, and R.E. Gerszten Metabolite profiles and the risk of developing diabetes Nat. Med. 17 4 2011 Apr 448 453
180. R. Wang-Sattler, Y. Yu, K. Mittelstrass, E. Lattka, E. Altmaier, C. Gieger, K.H. Ladwig, N. Dahmen, K.M. Weinberger, P. Hao, L. Liu, Y. Li, H.E. Wichmann, J. Adamski, K. Suhre, and T. Illig Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study PLoS One 3 12 2008 e3863
181. R. Wang-Sattler, Z. Yu, C. Herder, A.C. Messias, A. Floegel, Y. He, K. Heim, M. Campillos, C. Holzapfel, B. Thorand, H. Grallert, T. Xu, E. Bader, C. Huth, K. Mittelstrass, A. Döring, C. Meisinger, C. Gieger, C. Prehn, W. Roemisch-Margl, M. Carstensen, L. Xie, H. Yamanaka-Okumura, G. Xing, U. Ceglarek, J. Thiery, G. Giani, H. Lickert, X. Lin, Y. Li, H. Boeing, H.G. Joost, M.H. de Angelis, W. Rathmann, K. Suhre, H. Prokisch, A. Peters, T. Meitinger, M. Roden, H.E. Wichmann, T. Pischon, J. Adamski, and T. Illig Novel biomarkers for pre-diabetes identified by metabolomics Mol. Syst. Biol. 8 2012 615
182. R. Weikard, E. Altmaier, K. Suhre, K.M. Weinberger, H.M. Hammon, E. Albrecht, K. Setoguchi, A. Takasuga, and C. Kühn Metabolomic profiles indicate distinct physiological pathways affected by two loci with major divergent effect on Bos taurus growth and lipid deposition Physiol. Genomics 42A 2 2010 Oct 79 88
183. K.M. Weinberger Metabolomics in diagnosing metabolic diseases Ther. Umsch 65 9 2008 Sep 487 491 [Article in German]
184. K.M. Weinberger, and A. Graber Using comprehensive metabolomics to identify novel biomarkers Screen. Trends Drug Discov. 6 2005 42 45
185. Weinberger KM, Graber A, Ramsay SL (Inventors), Biocrates Life Sciences AG (Assignee), Biomarker and method for determining an oxidative stress level, International patent WO/2008/145385. Published 2008 Dec 4.
186. E.R. Werner, N. Blau, and B. Thöny Tetrahydrobiopterin: biochemistry and pathophysiology Biochem. J. 438 3 2011 Sep 15 397 414
187. W.R. Wikoff, M.A. Nagle, V.L. Kouznetsova, I.F. Tsigelny, and S.K. Nigam Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1) J. Proteom. Res. 10 6 2011 Jun 3 2842 2851
188. P. Würtz, P. Soininen, A.J. Kangas, T. Rönnemaa, T. Lehtimäki, M. Kähönen, J.S. Viikari, O.T. Raitakari, and M. Ala-Korpela Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults Diabetes Care 36 3 2013 Mar 648 655
189. R.J. Wurtman Tryptophan G. Adelman, B.H. Smith, Encyclopedia of Neuroscience third ed. 2004 Elsevier B.V Amsterdam, Netherlands
190. M. Wuttke, F. Schaefer, C.S. Wong, and A. Köttgen Genome-wide association studies in nephrology: using known associations for data checks Am. J. Kidney Dis. 65 2 2015 Feb 217 222
191. D. Yoshikawa, H. Ishii, S. Suzuki, K. Takeshita, S. Kumagai, M. Hayashi, T. Niwa, H. Izawa, and T. Murohara Plasma indoxyl sulfate and estimated glomerular filtration rate Circ. J. 78 10 2014 2477 2482
192. M. Yuille, G.J. van Ommen, C. Bréchot, A. Cambon-Thomsen, G. Dagher, U. Landegren, J.E. Litton, M. Pasterk, L. Peltonen, M. Taussig, H.E. Wichmann, and K. Zatloukal Biobanking for Europe Brief. Bioinform 9 1 2008 Jan 14 24
193. A.M. Zawada, K.S. Rogacev, S. Müller, B. Rotter, P. Winter, D. Fliser, and G.H. Heine Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease Epigenetics 9 1 2014 Jan 161 172
194. G. Zaza, S. Granata, F. Rascio, P. Pontrelli, M.P. Dell'Oglio, S.N. Cox, G. Pertosa, G. Grandaliano, and A. Lupo A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients BMC Med. Genomics 6 2013 May 10 17
195. J. Zhang, L. Yan, W. Chen, L. Lin, X. Song, X. Yan, W. Hang, and B. Huang Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system Anal. Chim. Acta 650 1 2009 16 22
196. W.Y. Zhao, L. Zeng, Y.H. Zhu, L.M. Wang, M.S. Zhou, S. Han, and L. Zhang A comparison of prediction equations for estimating glomerular filtration rate in Chinese potential living kidney donors Clin. Transpl. 23 4 2009 Aug-Sep 469 475
197. Y.Y. Zhao Metabolomics in chronic kidney disease Clin. Chim. Acta 422 2013 59 69
198. Y.Y. Zhao, and R.C. Lint Metabolomics in nephrotoxicity Adv. Clin. Chem. 65 2014 69 89
199. Y.Y. Zhao, X.L. Cheng, F. Wei, X.Y. Xiao, W.J. Sun, Y. Zhang, and R.C. Lin Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry Biomarkers 17 1 2012 48 55 2012 Feb
200. Y.Y. Zhao, J. Liu, X.L. Cheng, X. Bai, and R.C. Lin Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS Clin. Chim. Acta 413 5-6 2012 642 649 2012 Mar 22
201. Y.Y. Zhao, X.L. Cheng, F. Wei, X. Bai, and R.C. Lin Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique Biomarkers 17 8 2012 721 729 2012 Dec
202. Y.Y. Zhao, X. Shen, X.L. Cheng, F. Wei, X. Bai, and R.C. Lin Urinary metabonomics study on the protective effects of ergosta-4, 6, 8(14), 22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MS E data collection technique Process Biochem. 47 12 2012 1980 1987
203. Y.Y. Zhao, Y.L. Feng, X. Bai, X.J. Tan, R.C. Lin, and Q. Mei Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism PLoS One 8 3 2013 e59617
204. Y.Y. Zhao, L. Zhang, F.Y. Long, X.L. Cheng, X. Bai, F. Wei, and R.C. Lin UPLC-Q-TOF/HSMS/MS(E)-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one Chem. Biol. Interact. 201 1-3 2013 31 38 2013 Jan 25
205. Y.Y. Zhao, H.T. Li, Y.L. Feng, X. Bai, and R.C. Lin Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats J. Ethnopharmacol. 148 2 2013 403 410 10.1016/j.jep.2013.04.018 Epub 2013 Apr 21
206. Y.Y. Zhao, P. Lei, D.Q. Chen, Y.L. Feng, and X. Bai Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE J. Pharm. Biomed. Anal. 81-82 2013 202 209 10.1016/j.jpba.2013.03.028 Epub 2013 Apr 16
207. Y.Y. Zhao, H. Chen, T. Tian, D.Q. Chen, X. Bai, and F. Wei A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS PLoS One 9 12 2014 Dec 23 e115467
208. R.S. Barsoum Chronic kidney disease in the developing world N. Engl. J. Med 354 10 2006 Mar 9 997 999 PubMed PMID: 16525136
209. Q.L. Zhang, and D. Rothenbacher Prevalence of chronic kidney disease in population-based studies: systematic review BMC Public Health 8 2008 Apr 11 117 10.1186/1471-2458-8-117 (Review). PubMed PMID: 18405348; PubMed Central PMCID: PMC2377260